Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Indium-111 diethylenetriaminepentaacetate adenosylcobalamin - Mayo Clinic/Naviscan PET Systems

Drug Profile

Indium-111 diethylenetriaminepentaacetate adenosylcobalamin - Mayo Clinic/Naviscan PET Systems

Alternative Names: DTPA-adenosylcobalamin; In 111 DAC

Latest Information Update: 04 Nov 2017

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Mayo Clinic
  • Developer Mayo Clinic; Naviscan PET Systems
  • Class Heavy metals; Imaging agents; Radiopharmaceutical diagnostics
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • No development reported Cancer

Most Recent Events

  • 04 Nov 2017 No recent reports of development identified for phase-I development in Cancer(Diagnosis) in USA (Parenteral, Injection)
  • 10 Dec 2007 In 111 DAC is still in phase I trials for Diagnostic Imaging in USA
  • 01 Dec 2005 Mayo Clinic and Naviscan PET Systems have entered into licensing agreement for use of In 111 DAC as molecular imaging agent in cancer patients
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top